Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  American Journal of Medicine

• Publication date

  1984-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(84)90110-4PMID 6475990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic scleroderma.

  2020cited by this paper
• Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.

  1984cited by this paper
• Principles of rheumatic diseases

  1981cited by this paper
• The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis.

  1981cited by this paper
• Clinical significance of pulmonary function tests. Use and interpretation of the single-breath diffusing capacity.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• The CREST syndrome: a distinct serologic entity with anticentromere antibodies.

  1980cited by this paper
• A New Technique for Assessing Right Ventricular Ejection Fraction Using Rapid Multiple‐gated Equilibrium Cardiac Blood Pool Scintigraphy: Description, Validation and Findings in Chronic Coronary Artery Disease

  1979cited by this paper
• Pathologic Basis of Thallium-201 Scintigraphic Defects in Patients with Fatal Myocardial Injury

  1979cited by this paper
• Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

  1977cited by this paper
• The cardiac conduction system in progressive systemic sclerosis. Clinical and pathologic features of 35 patients.

  1976cited by this paper
• Rheumatic disorders in primary biliary cirrhosis.

  1976cited by this paper
• Myocardial Lesions of Progressive Systemic Sclerosis: A Cause of Cardiac Dysfunction

  1976cited by this paper
• Pericardial disease in scleroderma (systemic sclerosis).

  1974cited by this paper
• Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

  1971cited by this paper
• Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

  1969cited by this paper
• Myofibrillar degeneration. A response of the myocardial cell to injury.

  1968cited by this paper
• Myofibrillar degeneration. A response of the myocardial cell to injury.

  1968cited by this paper
• Calcinosis, Raynaud's phenomenon, sclerodactyly, and telangiectasia. The CRST syndrome.

  1967cited by this paper
• The heart in scleroderma.

  1966cited by this paper
• CRST syndrome. A benign variant of scleroderma.

  1965cited by this paper
• MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.

  1964cited by this paper
• MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.

  1964cited by this paper
• Systemic scleroderma, A clinical study of 727 cases.

  1961cited by this paper
• Progressive systemic sclerosis (scleroderma).

  1953cited by this paper
• ARTHRITIS AND ALLIED CONDITIONS

  1949cited by this paper
• SCLERODERMA HEART DISEASE: WITH A CONSIDERATION OF CERTAIN OTHER VISCERAL MANIFESTATIONS OF SCLERODERMA

  1943cited by this paper

• Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease

  2024cites this paper
• Diagnosis and management of primary heart involvement in systemic sclerosis.

  2023cites this paper
• The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study.

  2023cites this paper
• Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation

  2023cites this paper
• Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis.

  2023cites this paper
• Cardiac involvement in systemic sclerosis: Getting to the heart of the matter.

  2021cites this paper
• Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.

  2019cites this paper
• Defining primary systemic sclerosis heart involvement: A scoping literature review.

  2019cites this paper
• Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset

  2017cites this paper
• Chapter 13 – Systemic Sclerosis

  2017cites this paper
• Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course

  2016cites this paper
• Prolonged Tp-e interval and Tp-e/QT correlates well with modified Rodnan skin severity score in patients with systemic sclerosis.

  2016cites this paper
• Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.

  2015cites this paper
• Micro- and macrovascular treatment targets in scleroderma heart disease.

  2014cites this paper
• Tissue Doppler imaging in systemic sclerosis: a 3-year longitudinal study.

  2014cites this paper
• Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study

  2014cites this paper
• Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests

  2013cites this paper
• Identification of Myocardial Damage in Systemic Sclerosis: A Nuclear Cardiology Approach

  2010cites this paper
• Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.

  2010cites this paper
• Acute right heart failure and achalasia-like syndrome in a patient with limited cutaneous systemic sclerosis and primary biliary cirrhosis.

  2010cites this paper
• Manifestaciones clínicas en pacientes con esclerosis sistémica

  2009cites this paper
• The heart in scleroderma.

  2008cites this paper
• Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using Doppler measures of myocardial strain.

  2008cites this paper
• 3 SYSTEMIC SCLEROSIS Vascular , Pulmonary and Immunological Aspects

  2008cites this paper
• Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.

  2007cites this paper
• Echocardiographic alterations in systemic sclerosis: a longitudinal study.

  2005cites this paper
• Myocardial scintigraphy — 25 years after start

  2004cites this paper
• Assessment of heart involvement.

  2003cites this paper
• Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis.

  2003cites this paper
• Inflammatory Diseases of the Coronary Artery

  2002cites this paper
• Cardiorespiratory Responses during Exercise in Interstitial Lung Disease

  2002cites this paper
• Dipyridamole stress thallium perfusion scan for evaluating myocardial involvement in systemic sclerosis

  2001influential citation
• Thallium-201 myocardial SPET in patients with collagen disease

  2000cites this paper
• Cardiac Involvement in Limited Systemic Sclerosis: Non-invasive Assessment in Asymptomatic Patients

  1999cites this paper
• Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients.

  1998cites this paper
• Cardiovascular manifestations of systemic autoimmune diseases.

  1998cites this paper
• Manifestations of scleroderma pulmonary disease.

  1998cites this paper
• Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve.

  1996cites this paper
• Signal-averaged electrocardiography and echocardiography in the evaluation of myocardial involvement in progressive systemic sclerosis.

  1996cites this paper
• Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis.

  1996cites this paper
• Cardiac involvement in scleroderma.

  1996cites this paper
• Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis.

  1996cites this paper
• Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma).

  1996cites this paper
• A swinging heart in limited systemic sclerosis.

  1994cites this paper
• [Cardiac involvement in systemic scleroderma: the clinical aspects and current study methods].

  1994cites this paper
• Clinical exercise testing in interstitial lung disease.

  1994cites this paper
• Lung Disease in Systemic Sclerosis (Scleroderma)

  1993cites this paper
• Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.

  1993cites this paper
• Southwestern Internal Medicine Conference: The Many Faces of Scleroderma

  1992cites this paper
• Acute myocarditis in fulminant systemic sclerosis.

  1992cites this paper
• The many faces of scleroderma.

  1992cites this paper
• Left ventricular diastolic function in systemic sclerosis: assessment by radionuclide angiography.

  1992cites this paper
• The heart as a target organ of immune injury.

  1991cites this paper
• Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography.

  1991cites this paper
• A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

  1990cites this paper
• Southwestern Internal Medicine Conference: Clinical Features, Pathogenic Mechanisms, and New Developments in the Treatment of Systemic Sclerosis

  1990cites this paper
• Heart disease in systemic sclerosis.

  1989cites this paper
• [Nuclear medicine diagnosis of heart involvement in progressive systemic scleroderma].

  1989cites this paper
• Prognostic importance of cardiac arrhythmias in systemic sclerosis.

  1988cites this paper
• Cardiopulmonary manifestations of systemic sclerosis.

  1987cites this paper
• Einteilung und Klinik der progressiven systemischen Sklerodermie

  1987cites this paper
• [Nuclear antibodies as serologic markers in progressive systemic scleroderma].

  1987cites this paper
• Reversible myocardial perfusion defects during cold challenge in scleroderma.

  1986cites this paper
• The cardiovascular manifestations of systemic sclerosis (scleroderma).

  1986cites this paper
• Study of 102 Consecutive Cases with Functional Correlations and Review of the Literature

  1985cites this paper
• The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature.

  1985cites this paper